Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GITR agonists(Glucocorticoid-induced tumor necrosis factor receptor-related protein agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Kairos Pharma Ltd.Startup |
Active Organization Kairos Pharma Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | Kairos Pharma Ltd.Startup | 15 Mar 2022 |
Non-Small Cell Lung Cancer | Preclinical | US | Kairos Pharma Ltd.Startup | - |